A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Titel:
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Auteur:
Trachtman, Howard Fervenza, Fernando C. Gipson, Debbie S. Heering, Peter Jayne, David R.W. Peters, Harm Rota, Stefano Remuzzi, Giuseppe Rump, L. Christian Sellin, Lorenz K. Heaton, Jeremy P.W. Streisand, James B. Hard, Marjie L. Ledbetter, Steven R. Vincenti, Flavio